Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2395]
News [5726]
Articles [139]
Editorials [4]
Conferences [165]
elearning [13]
Gene cluster expression index and potential indications for targeted therapy and immunotherapy for lung cancers
Gene cluster expression index and potential indications for targeted therapy and immunotherapy for lung cancers
Treatment options for hepatocellular carcinoma using immunotherapy: present and future
Treatment options for hepatocellular carcinoma using immunotherapy: present and future
Inhibitory effect of miR-377 on prostate cancer cells
Inhibitory effect of miR-377 on prostate cancer cells
Scientists uncover promising treatment target for resistant brain cancer
Scientists uncover promising treatment target for resistant brain cancer
Revolutionising cancer treatment by intracellular protein delivery using hybrid nanotubes
Revolutionising cancer treatment by intracellular protein delivery using hybrid nanotubes
Scientists discover how deadly skin cancer evades the human immune system
Scientists discover how deadly skin cancer evades the human immune system
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced...
Phase 2 data for apalutamide plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localised prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery
Phase 2 data for apalutamide plus androgen deprivation therapy following radical prostatectomy in patients with...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation